Preponderance of High-Grade Histologic Subtype in Autologous Metastases in Lung Adenocarcinoma
To the Editor:
In 2015, the World Health Organization's new classification of lung tumors characterized lung adenocarcinoma (ADC) as a heterogeneous mixture of histologic subtypes (1) . Both predominance and presence of histologic subtypes in early-stage lung ADC have been reported to aid in prognostic stratification and therapeutic choice (2) (3) (4) (5) . Despite the increasing use and therapeutic significance of histologic subtypes in primary lung ADC, their incidence in metastatic tumors and relation to primary tumors remains unknown. Our study aimed to investigate the presence, distribution, and predominance of histologic subtypes of primary and autologous metastatic lung ADC tumors. This study was presented at the 17th World Conference on Lung Cancer, Vienna, Austria, December 4-7, 2016 (6).
Methods
We performed a retrospective review of our prospectively maintained Thoracic Surgery Service database of 4,093 patients who had undergone surgical resection for primary lung ADC at Memorial Sloan Kettering Cancer Center between January 1995 and December 2012. Of these, patients who had undergone surgical resection for pathologic stage I-III solitary primary lung ADC without induction therapy were eligible for inclusion. We excluded patients with 1) no recurrence identified during the follow-up period, 2) no available pathology specimens of either primary or autologous metastatic tumors, 3) tumors ,5 mm, or 4) local recurrence.
All recurrences were confirmed by cytologic or histologic evaluation. All available hematoxylin and eosin-stained tumor slides were reviewed by two experienced pathologists (S.L. and W.D.T.). Both primary and metastatic tumors were characterized according to the World Health Organization classification as lepidic, acinar (ACI), papillary, micropapillary (MIP), solid (SOL), and colloid in 5% increments (1) .
Second primary lung ADC was excluded from our study population and was defined as a tumor that meets one of the following three criteria: 1) histologically different from the index tumor; 2) similar histologic appearance to the index tumor but diagnosed more than 2 years after primary tumor diagnosis; or 3) similar histology to the index tumor and diagnosed within 2 years of treatment of the index tumor, but in a different lobe or segment without intervening positive lymph nodes and no evidence of metastatic disease. Cases in which the primary and secondary lesions were morphologically different or had differing gene mutation status were considered separate histologies (7). Data were compared using the Pearson chi-squared test with SPSS Statistics v24.0 (IBM Corporation).
Results
Our study cohort included 117 patients who had undergone surgical resection for metastatic tumors with adequate histology slides available for analysis ( Figure 1 ). Median age at the time of primary tumor surgery was 67.8 years (range, 38.9-86.1 yr), 76 patients (65%) were women, and 96 patients (82%) were either former or current smokers. The pathologic stage of the primary tumor was stage I in 61 (52%) patients, stage II in 38 (33%) patients, and stage IIIA in 18 (15%) patients. Resected metastatic sites included the brain (44 patients; 38%), lung (28 patients; 24%), lymph nodes (13 patients; 11%), pleura (10 patients; 9%), bone (8 patients; 7%), adrenal gland (5 patients; 4%), and other organs (9 patients; 8%).
Among the 117 patients, the most frequent predominant histologic subtype in their primary tumors was ACI in 53 (45%) patients, followed by SOL in 29 (25%) patients and papillary in 21 (18%) patients ( Figure 2 ). The most frequent predominant histologic subtype in autologous metastases was SOL in 61 (52%) patients, followed by ACI in 34 (29%) patients and MIP in 15 (13%) patients. As shown in Figure 2 , analysis of the percentage of histologic subtypes in primary tumors and autologous metastases in each case revealed an increasing incidence of the SOL histologic subtype in metastatic tumors. The presence of the SOL subtype was identified in 87 (74%) metastatic tumors. Metastases more frequently exhibited SOL predominance than the primary tumors (P , 0.001).
Discussion
To date, this is the largest series examining primary and matched metastases of lung ADC. The majority of autologous metastases exhibited SOL predominance, which was more frequent than in the primary tumors. As the majority of patients with lung ADC metastases do not undergo resection and are diagnosed only by fineneedle aspiration or needle biopsy, available tissue to perform histologic subtyping is limited. When comparing the SOL component percentage between primary and metastatic tumors, the majority of the patients (n = 98; 84%) had an increase in the percentage of the SOL pattern at the metastatic site compared with the primary site (SOL pattern-increased). The proportion of EGFR mutant tumors was lower in these SOL pattern-increased patients compared with those patients with SOL pattern decrease at metastatic sites (19% vs. 33%). By contrast, the proportion of KRAS mutant tumors was higher in the SOL pattern-increased patients than in the SOL pattern-decreased patients (38% vs. 17%). Distant metastatic sites frequently showed SOL predominance (55-80%), whereas lung metastases were more frequently ACI predominant (57%). Additionally, in patients with an ACI-predominant tumor at their primary site (n = 53), the predominant subtype at the metastatic site was usually ACI (45%, n = 24) or SOL (40%, n = 21). Even when the SOL subtype represented a small percentage of the primary lung ADC tumor composition, the majority of subsequent metastases demonstrated SOL predominance. This is suggestive of the aggressive nature of the SOL subtype and that this subtype may contribute to the metastatic process (8) . Clay and colleagues showed that the SOL subtype in metastatic tumor biopsy specimens was associated with a poor prognosis in stage IV lung ADC (9) . Patients with MIP-and SOL-predominant primary tumors reportedly showed better diseasefree survival among patients with lung ADC who had undergone adjuvant chemotherapy after surgical resection compared with those who had not (10) . This implies that tumor histologic subtypes can influence chemotherapeutic efficacy. Additionally, Zhang and colleagues reported that SOL-predominant lung ADC showed a In addition, the SOL subtype was identified in 87 (74%) metastatic tumors. The pie chart shows the predominant histologic subtype in tumors at primary sites and autologous metastases. The acinar (ACI) subtype, which was present in 53 (45%) patients, was the most common histologic subtype in primary tumors. The most common predominant histologic subtype in autologous metastases was the SOL subtype, which was present in 61 (52%) patients, followed by the ACI subtype in 34 (29%) patients and the micropapillary (MIP) subtype in 15 (13%) patients. COL = colloid; LEP = lepidic; PAP = papillary.
higher immunopositivity for programmed cell death ligand 1 (11) . Given the difference in therapeutic efficacy according to histologic subtype, our observations based on a thorough analysis of primary and matched metastases may have clinical significance. Our data suggests that the presence, even at a low percentage, of the SOL subtype in resected primary tumors should raise suspicion for the presence and/or predominance of the SOL subtype in metastatic tumors; this may, in turn, affect the choice of chemoimmunotherapies. n Author disclosures are available with the text of this letter at www.atsjournals.org.
